FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy

Texas kicks in for vegan vaccine funding

Free Newsletter

FiercePharma Manufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Sign up today to receive your FREE "insiders only" weekly pharma manufacturing industry briefing.



Tools

Oddly in line with last week's federal announcement setting in motion a medical countermeasures makeover in the U.S., the state of Texas is awarding $4 million for a production center that aims to churn out more than a billion doses annually of tobacco-plant-based influenza vaccine. The award comes from a Texas commission formed to help communities hurt by military base closures.

The money will fund facility construction at Bryan-College Station, on the Texas A&M Health Science Center campus, which is in the vicinity of a military base closed 50 years ago, says the Texas Tribune. The state has many more recent base closures that have affected their communities.

But Project GreenVax is spearheaded by the Texas Plant-Expressed Vaccine Consortium, which is based at the 145,000-square-foot National Center for Therapeutics Manufacturing located at Texas A&M. GreenVax occupies a 13,500-square-meter prefab unit comprising modules for tobacco-growing and research.

-see the article

Related Articles:
Tobacco may speed vax production
Sebelius report re-states need for vax-making makeover


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:

More stories about vaccine manufacturing   Influenza Vaccine Production   Texas